RecruitingNot applicableNCT05611268

Pentoxifylline as an Adjunct Therapy for Patients With Eisenmenger Syndrome

Studying Eisenmenger syndrome

Last synced from ClinicalTrials.gov May 8, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University of Sao Paulo General Hospital
Principal Investigator: Antonio Augusto Barbosa Lopes, MD
InCor Heart Institute
Intervention: Pentoxifylline(drug)
Enrollment: 48 enrolled
Eligibility: 10-80 years · All sexes
Timeline: 2022 – 2026

Study locations (1)

Antonio Augusto Barbosa Lopes, São Paulo, Brazil

Collaborators

InCor Heart Institute

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05611268 on ClinicalTrials.gov

Other trials for Eisenmenger syndrome

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE4NCT07356778
A Study of Sotatercept for Patients With Eisenmenger Syndrome or Unrepaired Shunt-Associated Pulmonary Arterial Hypertension Resistant to Vasodilator Therapy
Kazuya Hosokawa

See all trials for Eisenmenger syndrome →

← Back to all trials